| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Roberts David B | President and Director, Director | C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON | /s/ Laurie A. Churchill, Attorney-in-fact | 02 Mar 2026 | 0001365731 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LMAT | Common Stock | Award | $0 | +1,514 | +6.1% | $0.000000 | 26,444 | 26 Feb 2026 | Direct | F1 |
| transaction | LMAT | Common Stock | Award | $0 | +146 | +0.55% | $0.000000 | 26,590 | 26 Feb 2026 | Direct | F2 |
| transaction | LMAT | Common Stock | Options Exercise | $0 | +3 | +0.01% | $0.000000 | 26,593 | 26 Feb 2026 | Direct | F3 |
| transaction | LMAT | Common Stock | Tax liability | $15,234 | -134 | -0.5% | $113.69 | 26,456 | 26 Feb 2026 | Direct | F4 |
| transaction | LMAT | Common Stock | Tax liability | $1,478 | -13 | -0.05% | $113.69 | 26,443 | 26 Feb 2026 | Direct | F5 |
| transaction | LMAT | Common Stock | Sale | $903,958 | -8,464 | -32% | $106.80 | 17,979 | 27 Feb 2026 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LMAT | Dividend Equivalent Rights | Options Exercise | $0 | -3 | -24% | $0.000000 | 9 | 26 Feb 2026 | Common Stock | 3 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. |
| F2 | These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on February 18, 2025. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on December 6th over the next three years (2026, 2027 and 2028). |
| F3 | Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| F4 | These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| F5 | These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on February 18, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| F6 | The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.85 to $107.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. |
| F7 | These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |